Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells

The deoxycytidine analogue 2′,2′-difluoro-2′-deoxycytidine (dFdC, gemcitabine) is a potent radiosensitiser, but has limited efficacy in combination with radiotherapy in patients with pancreatic cancer due to acute toxicity. We investigated whether cyclopentenyl cytosine (CPEC), targetting the ‘de no...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van Bree, C, Rodermond, H M, Leen, R, Medema, J P, van Kuilenburg, A B P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2008
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359636/
https://ncbi.nlm.nih.gov/pubmed/18349845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604287
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak